Revision: Oct. 13, 2023, 4:47 p.m.
2024 SESSION
24-2378.0
05/08
HOUSE BILL [bill number]
AN ACT relative to the duties of the opioid abatement advisory commission.
SPONSORS: [sponsors]
COMMITTEE: [committee]
─────────────────────────────────────────────────────────────────
ANALYSIS
This bill defines integrated pain management and adds duties to the New Hampshire opioid abatement advisory commission involving support for pain management services.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
24-2378.0
05/08
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Four
AN ACT relative to the duties of the opioid abatement advisory commission.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 New Paragraph; Controlled Drug Prescription Health and Safety Program. Amend RSA 126-A:89 by inserting after paragraph VI the following new paragraph:
VI-a. "Integrative pain management" means the systematic combination of a variety of allopathic and non-allopathic services that address the biological, psychological, social, and spiritual needs of the patient. It is person-centered and focuses on maximizing function and wellness. Care plans are developed through a shared decision-making model that reflects the available evidence regarding optimal clinical practice and the person’s goals and values.
2 Opioid Abatement Advisory Commission; Duties. Amend RSA 126-A:86, I(b)(16) and (17) to read as follows:
(16) Support for public and non-public school programs and services for students with OUD and any co-occurring SUD/MH issues or who have been affected by OUD and any co-occurring SUD/MH issues within their family; [and]
(17) Support secondary and tertiary prevention through harm reduction programs[.];
(18) Support public and non-public services which support the pharmaceutical and non-pharmaceutical needs of patients with acute and/or chronic pain, and those with pain who are in hospice and/or palliative care who have responded well to opioid therapy as defined in RSA 318-B:41, II(d)(7), yet have been subject to non-consensual dose reduction or detoxification; and
(19) Support public and non-public services which increase access for those with acute and chronic pain and those with pain who are in hospice and/or palliative care to comprehensive integrative pain management services.
3 Effective Date. This act shall take effect 60 days after its passage.